BlackRock Investment Management, LLC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 22 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2016$56,000
+21.7%
6,590
-3.1%
0.00%
Q3 2016$46,000
+170.6%
6,803
+17.0%
0.00%
Q2 2016$17,000
+183.3%
5,815
+87.5%
0.00%
Q1 2016$6,000
+20.0%
3,1020.0%0.00%
Q4 2015$5,0000.0%3,1020.0%0.00%
Q3 2015$5,000
-50.0%
3,1020.0%0.00%
Q2 2015$10,0003,1020.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2015
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$27,550,00020.34%
AdvisorShares Investments LLC 380,750$2,079,0001.29%
ETF MANAGERS GROUP, LLC 5,779,642$31,557,0001.10%
DAFNA Capital Management LLC 297,300$1,623,0000.56%
GENERAL AMERICAN INVESTORS CO INC 632,400$3,453,0000.32%
Aries Wealth Management 27,900$160,0000.10%
Virtus ETF Advisers LLC 81,751$446,0000.07%
Omnia Family Wealth, LLC 21,726$119,0000.06%
HighVista Strategies LLC 12,200$67,0000.05%
WOODSTOCK CORP 57,213$312,0000.05%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders